RepliCel Life Company Insiders

RepliCel Life Management Team Effectiveness

The company has return on total asset (ROA) of (1.5334) % which means that it has lost $1.5334 on every $100 spent on assets. This is way below average. RepliCel Life's management efficiency ratios could be used to measure how well RepliCel Life manages its routine affairs as well as how well it operates its assets and liabilities. At this time, RepliCel Life's Return On Capital Employed is fairly stable compared to the past year. Return On Equity is likely to climb to 0.07 in 2024, whereas Return On Tangible Assets are likely to drop (1.14) in 2024. At this time, RepliCel Life's Other Current Assets are fairly stable compared to the past year. Debt To Assets is likely to climb to 3.19 in 2024, whereas Non Current Assets Total are likely to drop slightly above 119.4 K in 2024. Common Stock Shares Outstanding is likely to climb to about 62.2 M in 2024, whereas Net Loss is likely to drop (4.9 M) in 2024.

RepliCel Life Workforce Comparison

The company has Profit Margin (PM) of 2.16 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is normal as compared to the sector avarege. Similarly, it shows Operating Margin (OM) of (0.74) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.74.

RepliCel Life Sciences Benchmark Summation

RepliCel Life Notable Stakeholders

The success or failure of an entity such as RepliCel Life Sciences often depends on how effective the management is. RepliCel Life management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of RepliCel management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the RepliCel management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

Please note, the imprecision that can be found in RepliCel Life's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of RepliCel Life Sciences. Check RepliCel Life's Beneish M Score to see the likelihood of RepliCel Life's management manipulating its earnings.

When running RepliCel Life's price analysis, check to measure RepliCel Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy RepliCel Life is operating at the current time. Most of RepliCel Life's value examination focuses on studying past and present price action to predict the probability of RepliCel Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move RepliCel Life's price. Additionally, you may evaluate how the addition of RepliCel Life to your portfolios can decrease your overall portfolio volatility.